» Articles » PMID: 27314298

Polymorphisms in Selected DNA Repair Genes and Cell Cycle Regulating Genes Involved in the Risk of Papillary Thyroid Carcinoma

Overview
Journal Cancer Biomark
Publisher Sage Publications
Specialties Biochemistry
Oncology
Date 2016 Jun 18
PMID 27314298
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Papillary thyroid carcinoma (PTC) is the most common type of thyroid cancer. In addition to causal somatic mutations in the BRAF gene and RET/PTC rearrangements, the contribution of single nucleotide polymorphisms (SNPs) in low-penetrance genes in the development of PTC has been proposed.

Methods: Four SNPs in the XRCC1 (Arg399Gln, Arg280His, Arg194Trp and T-77C) and one SNP from each of three other genes participating in DNA repair pathways and/or cell cycle regulation (ATM Asp1853Asn, TP53 Arg72Pro, CDKN1B Val109Gly) were selected. The allelic and genotypic distributions of these variants as well as haplotypes of the XRCC1 were examined in 583 individuals comprising well-characterized cohorts of 209 PTC patients and 374 healthy volunteers. Correlations of polymorphism with clinical-pathological data and mutation status were performed.

Results: XRCC1 T-77C polymorphism affects the genetic susceptibility for PTC development in men, the specific combination of XRCC1 haplotypes correlates with RET/PTC incidence, CDKN1B Val109Gly significantly influences the risk of developing PTC regardless of gender and in PTC cases, selected genotypes of TP53 Arg72Pro and ATM Asp1853Asn were significantly associated with monitored tumour characteristics.

Conclusion: It seems that SNPs in studied regulating genes contribute to the development of PTC and modify the tumour behaviour or characteristics.

Citing Articles

Polymorphisms of DNA Repair Genes in Thyroid Cancer.

Gielecinska A, Kciuk M, Kolat D, Kruczkowska W, Kontek R Int J Mol Sci. 2024; 25(11).

PMID: 38892180 PMC: 11172789. DOI: 10.3390/ijms25115995.


A Meta-Analysis for Association of XRCC1, XRCC2 and XRCC3 Polymorphisms with Susceptibility to Thyroid Cancer.

Mandegari M, Dastgheib S, Asadian F, Shaker S, Tabatabaie S, Kargar S Asian Pac J Cancer Prev. 2021; 22(7):2221-2236.

PMID: 34319046 PMC: 8607094. DOI: 10.31557/APJCP.2021.22.7.2221.


Somatic Mutation Profiling of Papillary Thyroid Carcinomas by Whole-exome Sequencing and Its Relationship with Clinical Characteristics.

Qi T, Rong X, Feng Q, Sun H, Cao H, Yang Y Int J Med Sci. 2021; 18(12):2532-2544.

PMID: 34104084 PMC: 8176168. DOI: 10.7150/ijms.50916.


Germline CDKN1B Loss-of-Function Variants Cause Pediatric Cushing's Disease With or Without an MEN4 Phenotype.

Chasseloup F, Pankratz N, Lane J, Faucz F, Keil M, Chittiboina P J Clin Endocrinol Metab. 2020; 105(6).

PMID: 32232325 PMC: 7190031. DOI: 10.1210/clinem/dgaa160.


Thyroid Cancer: The Quest for Genetic Susceptibility Involving DNA Repair Genes.

S Santos L, Gomes B, Bastos H, M Gil O, Azevedo A, Ferreira T Genes (Basel). 2019; 10(8).

PMID: 31374908 PMC: 6722859. DOI: 10.3390/genes10080586.